CUE CIK: 1645460

Cue Biopharma, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−38.8
FY22:
−41.8
FY23:
−40.0
FY24:
−36.3
FY25:
−21.7
Change from FY21 to FY25
millions USD
FY21:
9.11
FY22:
−24.6
FY23:
25.0
FY24:
0.03
FY25:
0.08
Change from FY21 to FY25
millions USD
FY21:
19.2
FY22:
53.7
FY23:
11.9
FY24:
10.2
FY25:
26.3
millions USD
FY21:
−10.5
FY22:
−12.8
FY23:
−3.10
FY24:
−26.1
FY25:
4.68
(positive)
Change from FY21 to FY25
millions USD
FY21:
−39.8
FY22:
−42.0
FY23:
−40.0
FY24:
−36.4
FY25:
−21.9

All amounts in millions USD Data source:SEC EDGAR